Advances in vaccine technology

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Human papillomaviruses (HPVs) are the causative agent for recurrent respiratory papillomatosis, cancer of the cervix, and squamous cell carcinoma of the head and neck. Vaccines are available to prevent infection with several of the HPV types that are responsible for causing these serious diseases. This chapter discusses the development, successes, and limitations of these prophylactic L1-based vaccines. Potential for L2-based vaccines to provide broad coverage to prevent infection with many HPV types is also discussed. Finally, research into treatment of established HPV infection and resultant disease using therapeutic vaccines is outlined.

Original languageEnglish (US)
Title of host publicationRecurrent Respiratory Papillomatosis
PublisherSpringer International Publishing
Pages45-58
Number of pages14
ISBN (Electronic)9783319638232
ISBN (Print)9783319638225
DOIs
StatePublished - Jan 1 2017

    Fingerprint

Keywords

  • Cervarix
  • Gardasil
  • Human papillomavirus
  • Recurrent respiratory papillomatosis
  • Vaccine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ahn, J., Best, S. R., & Tunkel, D. E. (2017). Advances in vaccine technology. In Recurrent Respiratory Papillomatosis (pp. 45-58). Springer International Publishing. https://doi.org/10.1007/978-3-319-63823-2_4